TRANS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE, 95.0%, 1g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(2S,4R)-1-((S)-2-((Cyclopentyloxy)carbonyl)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 1g

cis-2,6-Dimethylpiperidine>99.0%(GC)(T)100mL

(E)-4-CHLORO-2-(3-(4-PENTYLPHENYL)ACRYLAMIDO)BENZOIC ACID, 95.0%, 1g

3-Aminopyrrolidine Dihydrochloride>98.0%(HPLC)(N)25g

N-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95%, 5g

4-Fluoroaniline Hydroiodide>98.0%(T)(HPLC)1g

(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid, 95.0%, 500mg

(R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde(50% in Chlorocyclohexane), 95%, 100mg

(3-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid, 97%, 10g

2,2'-Thiobis(4-tert-octylphenol)>95.0%(GC)25g

(2S,3S,4R)-2-Aminooctadecane-1,3,4-triol, 95.0%, 10g